CompletedNot Applicable

Proenkephalin for Prediction of Contrast-Associated Kidney Events

Germany220 participantsStarted 2018-07-01

Plain-language summary

Currently, contrast-induced kidney injury cannot be diagnosed on the day of cardiac catheterization. Recently, proenkephalin (penKid) was introduced as a new glomerular filtration marker. The aim of this study is to investigate whether the change in penKid level allows for early detection of affected patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \> 18 years of age * Planned elective or urgent coronary or non-coronary angiography with iodinated contrast media * Ability to provide informed consent Exclusion Criteria: * Current use of renal replacement therapy/hemodialysis * life expectancy \< 6 months

What they're measuring

Sustained kidney injury

Timeframe: Time period between the two time-points: immediately before catherization and 4-8 weeks after discharge

Trial details

NCT IDNCT03989505

SponsorDr. med. Mahir Karakas

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12-01

View on ClinicalTrials.gov More Contrast-induced Nephropathy trials